U.S. Markets open in 18 mins

How Novavax plans to advance after failed drug trial, delisting threat

Sara Gilgore
How Novavax plans to advance after failed drug trial, delisting threat

The company will put into effect a reverse stock split of its issued and outstanding common stock, a move intended to increase its share price.